These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 899478)

  • 1. [Effect of moditen-depot therapy on the duration and quality of remissions in schizophrenia patients].
    Vovin RIa; Gurovich IIa; Eryshev OF; Zaĭtsev SG; Magalif AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(5):743-9. PubMed ID: 899478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
    Abramova LI; Gushanskiĭ EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):419-24. PubMed ID: 3705854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
    Gamburg AL; Aranovich AG; Kotel'kevich IuN; Omorokov BM; Rasniuk VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the therapeutic effectiveness of mirenil prolongatum and moditen depot in the treatment of schizophrenia].
    Afeltowicz Z; Sep-Kowalikowa B; Zgirski L
    Psychiatr Pol; 1976; 10(5):479-85. PubMed ID: 981421
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Ushakov IuV; Kravchenko NE; Kopeĭko GI; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):99-104. PubMed ID: 1979463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-economical aspects of long-term therapy with moditen-depot].
    Ushakov IuV; Kravchenko NE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(12):67-9. PubMed ID: 1965375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with the depot neuroleptic LyogenR-depot].
    Bach O; Petermann H; Geppert V
    Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Remarks on the action of Moditen-retard and Modecate. Apropos of 65 cases].
    Scherrer P; Quiniou-Vidalenc
    Ann Med Psychol (Paris); 1976 Nov; 2(4):642-56. PubMed ID: 1020862
    [No Abstract]   [Full Text] [Related]  

  • 11. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
    Friemert K; Beier R; Vehreschild T
    Psychiatr Neurol Med Psychol (Leipz); 1974 Jun; 26(6):374-7. PubMed ID: 4849639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
    Vovin RIa; Vovina EN
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():183-7. PubMed ID: 829620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of long-term treatment with depot neuroleptics in schizophrenic patients].
    Klein A; Ehle G
    Psychiatr Neurol Med Psychol (Leipz); 1988 Mar; 40(3):159-67. PubMed ID: 3132729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of remissions in adolescents with paroxysmal schizophrenia who have suffered catatono-oneiroid episodes].
    Simashkova NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):86-91. PubMed ID: 3953200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 18. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR; Levine J; Severe JB
    Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
    Pirozynski T; Chiriţă V; Cosmovici N; Offenberg C; Chiriac ME; Marinescu V; Cojocaru M; Berlescu M; Mungiu A
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):501-9. PubMed ID: 2700035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.